Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PH

Peter Hansen — 13 Patents

Astrazeneca Ab: 10 patents #96 of 1,971Top 5%
KAKefalas A/S: 3 patents #3 of 10Top 30%
Lillerød, DK: #6 of 133 inventorsTop 5%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Peter Hansen has been granted 13 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1981 and the most recent in August 2013. Peter Hansen ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Peter Hansen in Lillerød, DK.

Patents per Year

Patents granted per year, 1981 to 2013Bar chart with a peak of 3 patents in 2005.peak 31981: 2 patents19811982: 1 patents19822005: 3 patents20052011: 2 patents20112012: 3 patents20122013: 2 patents2013

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use Marjana Andersson, Hans Roland LONN, Antonios Nikitidis, Petter Sjölin 2013-08-06 $10,790,000
8410114 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial Marianne Ivarsson, Karolina Lawitz, Hans Roland LONN, Antonios Nikitidis, Asim Ray 2013-04-02 $12,291,000
8338587 Compounds Frank Burkamp, Balint Gabos, Håkan Bladh 2012-12-25
8163724 Glucocorticosteroids, processes for their preparation, pharmaceutical compositions containing them and their use in therapy Håkan Bladh, Frank Burkamp, Balint Gabos, Svetlana Ivanova, Karolina Lawitz 2012-04-24 $2,945,000
8114881 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial Marianne Ivarsson, Karolina Lawitz, Hans Roland LONN, Antonios Nikitidis, Asim Ray 2012-02-14 $6,101,000
8063073 2-pyridone derivatives as neutrophil elastase inhibitors and their use Hans Roland LONN, Antonios Nikitidis 2011-11-22 $3,731,000
7998984 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial Karolina Lawitz, Matti Lepisto, Hans Roland LONN, Asim Ray 2011-08-16 $21,058,000
6951874 Compounds Lars Pettersson 2005-10-04 $22,350,000
6943188 Hydroxyalkyl compounds Tomas Eriksson, Martin Hemmerling, Krister Henriksson, Tomas Klingstedt, Lars Pettersson +1 more 2005-09-13 $13,325,000
6927222 Compounds Lars Pettersson 2005-08-09 $40,365,000
4309429 Xanthene and thioxanthene derivatives, compositions thereof, and treatment therewith Niels Lassen, Klaus Bogeso, Jorn L. M. Buus, Allan J. Bigler 1982-01-05
4285956 Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith Niels Lassen, Klaus P. Boges, Jorn L. M. Buus, Allan J. Bigler 1981-08-25
4275209 Xanthene and thioxanthene derivatives Niels Lassen, Klaus Bogeso, Jorn L. M. Buus, Allan J. Bigler 1981-06-23